Hypertension and cardiotoxicity in metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU)

被引：0
|
作者：
Prati, Veronica
Ortega, Cinzia
Ballatore, Valentina
Galizia, Danilo
Ruatta, Fiorella
Bonzano, Alessandro
Aliberti, Sandra
Grignani, Giovanni
Aglietta, Massimo
机构：
[1] Fdn Piemonte Oncol, Inst Canc Res & Treatment, Candiolo, Italy
[2] Fdn Piemonte Oncol, Inst Canc Res & Treatment, Cardiol Unit, Turin, Italy
[3] Univ Turin, Inst Canc Res & Treatment, Candiolo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15073
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    [J]. ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [2] Pre-existing hypertension is an independent prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with sunitinib (SU)
    Derosa, Lisa
    Izzedine, Hassane
    Le Teuff, Gwenael
    Albiges, Laurence
    Escudier, Bernard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] SUNITINIB (SU) RECHALLENGE IN METASTATIC RENAL CELL CARCINOMA (MRCC): A SINGLE INSTITUTION EXPERIENCE
    Febbraro, Antonio
    Giordano, Guido
    [J]. ANTICANCER RESEARCH, 2014, 34 (05) : 2626 - 2627
  • [6] Long-term safety with sunitinib (SU) in metastatic renal cell carcinoma (mRCC)
    Porta, C.
    Gore, M. E.
    Rini, B. I.
    Escudier, B.
    Charles, L. P.
    Chen, L.
    Hariharan, S.
    Motzer, R. J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S658 - S658
  • [7] Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).
    Kushnir, Igal
    Rosenbaum, Eli
    Sarid, David Leonid
    Sella, Avishay
    Gottfried, Maya
    Maimon, Natalie
    Peer, Avivit
    Neumann, Avivit
    Neiman, Victoria
    Kovel, Svetlana
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Berger, Raanan
    Keizman, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).
    Kushnir, Igal
    Rosenbaum, Eli
    Sella, Avishay
    Sarid, David
    Gottfried, Maya
    Maimon, Natalie
    Peer, Avivit
    Neumann, Avivit
    Neiman, Victoria
    Kovel, Svetlana
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Berger, Raanan
    Keizman, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] Characterizing fatigue associated with sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Cella, David
    Davis, Mellar P.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Hahn, Elizabeth A.
    Korytowsky, Beata
    Bhattacharyya, Helen
    Sandin, Rickard
    Beaumont, Jennifer L.
    Matczak, Ewa
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Is there a "trial effect" on outcome of patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Carducci, Michael Anthony
    Berger, Raanan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345